The MARPELLA risk score for prediction of mortality in all-cause refractory cardiogenic shock treated with microaxial transvalvular pump: the MARPELLA study

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Acute cardiac care 1 Cardiogenic Shock ESC Professional Premium Access ESC Congress 2022

ESC 365 is supported by

ESC 365 is supported by